Clinical-stage stem cell and regenerative medicine firm Cynata has four trials underway, three ending between late this year ...

Among the small caps in the hot Brazilian rare earths space, there’s one that’s taking a lead in the race to a non-Chinese ...

Strata Minerals (ASX:SMX) has significantly boosted its exploration portfolio by completing the acquisition of the Penny ...

There’s no shortage of junior gold explorers and developers on the ASX but what Astral Resources is sitting on is ...

By strategically booking holidays around key public holidays, employees in certain Aussie states can maximise their annual ...

The history of demergers shows the two new Webjet companies have more of a chance of creating shareholder value than if ...

Fortescue (ASX:FMG) surged by nearly 5% as iron ore prices continued to rise on the China news, hitting US$100.30 per tonne.

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes ...

The rise and fall of Novo Resources is a cautionary tale about over-promotion, but its Pilbara gold prospects could yet yield ...

Morgans analyst Scott Power provides his thoughts on Healius (ASX:HLS) selling its radiology arm for an enterprise value of $965m.

Social media has torn apart Coles and Woolworths' ESG reputations this week, with the duopoly accused of misleading pricing ...

Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) announced today it is undertaking a $20 million ...